Inventor
ZHAO ZUCHUN
US39 patents
⚠️ This page may combine multiple inventors who share the name “ZHAO ZUCHUN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
BERLEX LAB
13 patentsUS6432947B1Aug 13, 2002
N-heterocyclic derivatives as NOS inhibitors
BERLEX LAB89 citations98
US6140351AOct 31, 2000
Ortho-anthranilamide derivatives as anti-coagulants
BERLEX LAB179 citations97
US5849759ADec 15, 1998
Naphthyl-substituted benzimidazole derivatives as anti-coagulants
BERLEX LAB79 citations95
US6350761B1Feb 26, 2002
Benzenamine derivatives as anti-coagulants
BERLEX LAB22 citations92
US6380221B1Apr 30, 2002
Ortho-anthranilamide derivatives as anti-coagulants
BERLEX LAB33 citations91
US6498185B1Dec 24, 2002
Ortho-anthranilamide derivatives as anti-coagulants
BERLEX LAB14 citations82
US6747031B2Jun 8, 2004
N-heterocyclic derivatives as NOS inhibitors
BERLEX LAB6 citations73
US6670473B2Dec 30, 2003
N-heterocyclic derivatives as NOS inhibitors
BERLEX LAB3 citations73
US6849739B2Feb 1, 2005
N-heterocyclic derivatives as NOS inhibitors
BERLEX LAB1 citations62
US6846829B2Jan 25, 2005
N-heterocyclic derivatives as NOS inhibitors
BERLEX LAB1 citations62
US6841674B2Jan 11, 2005
N-heterocyclic derivatives as NOS inhibitors
BERLEX LAB2 citations62
US6864263B2Mar 8, 2005
N-heterocyclic derivatives as NOS inhibitors
BERLEX LAB0 citations52
US6841673B2Jan 11, 2005
N-heterocyclic derivatives as nos inhibitors
BERLEX LAB0 citations52
METABOLEX INC
9 patentsUS7638541B2Dec 29, 2009
5-ethyl-2-{4-[4-(4-tetrazol-1-yl-phenoxymethyl)-thiazol-2-yl]-piperidin-1-yl}-pyrimidine
METABOLEX INC43 citations95
US6624194B1Sep 23, 2003
Use of (−) (3-trihalomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of insulin resistance, type 2 diabetes, hyperlipidemia and hyperuricemia
METABOLEX INC38 citations92
US7714131B2May 11, 2010
Process for the stereoselective preparation of (−)-halofenate and derivatives thereof
METABOLEX INC9 citations84
US7432394B2Oct 7, 2008
Resolution of α-(phenoxy) phenylacetic acid derivatives with naphthyl-alkylamines
METABOLEX INC12 citations84
US7371888B2May 13, 2008
α-(Trifluoromethyl-substituted aryloxy, arylamino, arylthio or arylmethyl)-trifluoromethyl-substituted phenylacetic acids and derivatives as antidiabetic agents
METABOLEX INC3 citations61
US7078421B2Jul 18, 2006
Substituted phenylacetic acids
METABOLEX INC4 citations61
US7622491B2Nov 24, 2009
Modulators of PPAR and methods of their preparation
METABOLEX INC4 citations60
US7323480B2Jan 29, 2008
Substituted triazoles as modulators of PPAR and methods of their preparation
METABOLEX INC6 citations60
US7642358B2Jan 5, 2010
Substituted phenylacetic acids
METABOLEX INC1 citations51
SCHERING AG
7 patentsUS6555537B2Apr 29, 2003
Piperazine derivatives and their use as anti-inflammatory agents
SCHERING AG24 citations92
US6534509B1Mar 18, 2003
Piperazine derivatives and their use as anti-inflammatory agents
SCHERING AG19 citations92
US6541476B1Apr 1, 2003
Piperazine derivatives and their use as anti-inflammatory agents
SCHERING AG3 citations73
US7268140B2Sep 11, 2007
Piperazine derivatives and their use as anti-inflammatory agents
SCHERING AG0 citations52
US6977258B2Dec 20, 2005
Piperazine derivatives and their use as anti-inflammatory agents
SCHERING AG0 citations52
US6972290B2Dec 6, 2005
Piperazine derivatives and their use as anti-inflammatory agents
SCHERING AG0 citations52
US6573266B1Jun 3, 2003
Piperazine derivatives and their use as anti-inflammatory agents
SCHERING AG0 citations52
CHEN XIN
3 patentsUS8227495B2Jul 24, 2012
2,4-disubsituted thiazoles and pharmaceutical compositions thereof
CHEN XIN13 citations92
US8288384B2Oct 16, 2012
Heterocyclic receptor agonists for the treatment of diabetes and metabolic disorders
CHEN XIN9 citations91
US8975258B2Mar 10, 2015
Heterocyclic receptor agonists for the treatment of diabetes and metabolic disorders
CHEN XIN0 citations51
CYMABAY THERAPEUTICS INC
3 patentsUS9737537B2Aug 22, 2017
Heterocyclic receptor agonists for the treatment of diabetes and metabolic disorders
CYMABAY THERAPEUTICS INC1 citations62
US9925189B2Mar 27, 2018
Heterocyclic receptor agonists for the treatment of diabetes and metabolic disorders
CYMABAY THERAPEUTICS INC0 citations51
US8921350B2Dec 30, 2014
Heterocyclic receptor agonists for the treatment of diabetes and metabolic disorders
CYMABAY THERAPEUTICS INC0 citations51